<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> may develop various lung manifestations </plain></SENT>
<SENT sid="1" pm="."><plain>The lung complications that have been described so far are pulmonary <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo>, <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002098'>respiratory distress</z:hpo> syndrome, primary <z:mp ids='MP_0005048'>thrombosis</z:mp> of large and <z:mp ids='MP_0003641'>small lung</z:mp> vessels, diffuse alveolar haemorrhage, fibrosing <z:mp ids='MP_0010922'>alveolitis</z:mp> and postpartum syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>Clinicians should be aware of these conditions as in most of these cases, timely diagnosis and treatment is needed </plain></SENT>
</text></document>